Former President Joe Biden‘s late-stage prostate cancer diagnosis has ignited debate about early detection protocols and whether the White House health team failed the former commander-in-chief. Biden’s team revealed that he received a diagnosis last week following complaints of urinary issues.

Former President Joe Biden’s diagnosis of an aggressive, stage-4 prostate cancer has reignited a long-simmering medical debate: When should men get screened for prostate cancer? For decades, doctors have wrestled with how often to screen men for the disease and when to start and stop.

Now, the former president, 82, faces his own cancer diagnosis. On May 18, a spokesperson for Biden said he had been diagnosed with an "aggressive form" of prostate cancer. At times, grief was said to have stalled Biden’s ambitions.

While House Republicans and Trump appear to be aligned in their desire to investigate Biden’s fitness to serve, there is some frustration brewing among congressional committees about how quickly the Trump administration is responding to some of their requests, according to multiple GOP congressional sources familiar with the matter.

Trump and House Republicans lobbed an aggressive push to investigate Biden’s autopen use, questioning whether aides acted without his consent.